Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2018 Sep 6;2018:9878120. doi: 10.1155/2018/9878120

Corrigendum to “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway”

Dacheng Wu 1,2, Keyan Wu 1,2, Qingtian Zhu 2, Weiming Xiao 1,2, Qing Shan 2, Zhigang Yan 1,2, Jian Wu 1,2, Bin Deng 1,2, Yan Xue 1,2, Weijuan Gong 1,2,3, Guotao Lu 1,2, Yanbing Ding 1,2,
PMCID: PMC6146555  PMID: 30297978

In the article titled “Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway” [1], the protein labels in Figures 6(h) and 6(i) were reversed and should be corrected as follows:

Figure 6.

Figure 6

NLRP3 inhibitor MCC950 eliminated the protective effect of H-For on acute colitis in mice. (a) The experimental protocol with For and MCC950 in an acute colitis model. (b) Body weights of mice and (c) disease activity index (DAI) during the disease process. (d) Morphological changes in the mouse colons, (e) variations of colon length of mice, (f) representative HE staining, and (g) histological scores of colonic tissue. (h) Protein levels of claudin-1, occludin, and ZO-1 and (i) NLRP3, ASC, and IL-1β were analyzed by western blotting. p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

References

  • 1.Wu D., Wu K., Zhu Q., et al. Formononetin administration ameliorates dextran sulfate sodium-induced acute colitis by inhibiting NLRP3 inflammasome signaling pathway. Mediators of Inflammation. 2018;2018:12. doi: 10.1155/2018/3048532.3048532 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES